Heron Therapeutics, Inc. (NASDAQ:HRTX) Sees Large Growth in Short Interest

Heron Therapeutics, Inc. (NASDAQ:HRTX – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 30,270,000 shares, an increase of 10.9% from the April 30th total of 27,290,000 shares. Based on an average daily volume of 2,410,000 shares, the short-interest ratio […]

Related Keywords

Monaco , ,Nasdaq ,Needham Company ,Tejara Capital Ltd ,Congress Park Capital ,Heron Therapeutics Company Profile ,Heron Therapeutics Inc ,Heron Therapeutics ,Get Free Report ,One Financial ,Capital Management ,Asset Management ,Spark Capital ,Capital Partners ,Capital Ltd ,Heron Therapeutics Daily ,